TTFields（Tumor Treating Fields）
Showing 1 - 25 of >10,000
Non Small Cell Lung Cancer Trial in Salt Lake City (radiation, device, drug)
Not yet recruiting
- Non Small Cell Lung Cancer
- carboplatin chemotherapy
- +2 more
-
Salt Lake City, UtahHuntsman Cancer Institute
Nov 3, 2023
Adenocarcinoma of Lung Trial in United States (NovoTTF-200T System)
Not yet recruiting
- Adenocarcinoma of Lung
- NovoTTF-200T System
-
Basking Ridge, New Jersey
- +6 more
Mar 3, 2023
Glioma Trial in Atlanta (Optune device)
Recruiting
- Glioma
- Optune device
-
Atlanta, Georgia
- +2 more
May 12, 2022
GBM, Glioma Glioblastoma Multiforme, Tumor, Brain Trial (Whole Brain Spectroscopy Imaging Array Mapping Layout)
Recruiting
- GBM
- +2 more
- Whole Brain Spectroscopy Imaging Array Mapping Layout
-
Philadelphia, Pennsylvania
- +1 more
Jan 19, 2023
Pancreatic Adenocarcinoma, Resectable Pancreatic Cancer Trial (Nab paclitaxel, Gemcitabine, NovoTTF-200T)
Not yet recruiting
- Pancreatic Adenocarcinoma
- Resectable Pancreatic Cancer
- Nab paclitaxel
- +2 more
- (no location specified)
Dec 5, 2022
Glioblastoma, Recurrent Glioblastoma, GBM Trial in Philadelphia (drug, device, procedure)
Recruiting
- Glioblastoma
- +2 more
- Niraparib
- +2 more
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Jul 16, 2021
Newly Diagnosed Glioblastoma in Patients =70 Years Trial in Heidelberg (TTFields)
Suspended
- Newly Diagnosed Glioblastoma in Patients ≥70 Years
- TTFields
-
Heidelberg, GermanyUniversity Hospital of Heidelberg, Radiation Oncology
Sep 28, 2021
Non Small Cell Lung Cancer, EGFR Gene Mutation, Immune Checkpoint Inhibitor Trial in Jerusalem (concomitant TTFields treatment
Not yet recruiting
- Non Small Cell Lung Cancer
- +2 more
- concomitant TTFields treatment device to standard of care EGFR positive NSCLC treatment
- concomitant TTFields treatment device to standard of care anti PD-1 NSCLC treatment
-
Jerusalem, IsraelShaare Zedek Medical Center
Jan 22, 2023
COVID-19 Trial in Jerusalem (NovoTTF-100L)
Completed
- COVID-19
- NovoTTF-100L
-
Jerusalem, IsraelHadassah Medical Center
Jul 4, 2021
NSCLC Trial in United States (NovoTTF-200T)
Recruiting
- Non-small Cell Lung Cancer
- NovoTTF-200T
-
Birmingham, Alabama
- +21 more
Aug 15, 2022
Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma of Unknown Primary, Metastatic Malignant Tumor in the Brain Trial in
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +6 more
- Ipilimumab
- +4 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Dec 12, 2022
Recurrent Glioblastoma Multiforme Trial in Guangzhou (TTFields)
Recruiting
- Recurrent Glioblastoma Multiforme
- TTFields
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Dec 25, 2020
Glioblastoma, Newly Diagnosed Glioblastoma Trial in Stanford (device, drug, radiation)
Recruiting
- Glioblastoma
- Newly Diagnosed Glioblastoma
- Optune
- +3 more
-
Stanford, CaliforniaStanford University
Aug 1, 2022
Malignant Glioma, Ependymoma Trial in United States (Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields))
Active, not recruiting
- Malignant Glioma
- +2 more
- Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields)
- Concurrent Optune and RT followed by Optune System alone
-
Los Angeles, California
- +8 more
Jan 17, 2023
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Malignant Tumor in the Leptomeninges Trial in
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +2 more
- Digital Photography
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Feb 28, 2023
Glioblastoma, Glioma, Gliosarcoma Trial in United States (Bevacizumab, TTFields Therapy)
Terminated
- Glioblastoma
- +2 more
- Bevacizumab
- TTFields Therapy
-
La Jolla, California
- +10 more
May 12, 2021
NovoTTF Treatment Signatures in Glioblastoma Patients at Autopsy
Recruiting
- Glioblastoma
- Tumor samples from patients treated with TTFields at initial diagnosis.
- Tumor samples from patients treated with TTFields at tumor recurrence.
-
Milwaukee, WisconsinFroedtert & the Medical College of Wisconsin
Feb 9, 2022
Gastric Cancer, GastroEsophageal Cancer Trial in Hong Kong (NovoTTF-100L(P), Oxaliplatin, Capecitabine)
Unknown status
- Gastric Cancer
- GastroEsophageal Cancer
- NovoTTF-100L(P)
- +3 more
-
Hong Kong, Hong KongQueen Mary Hospital
Jun 24, 2020
Nonsmall Cell Lung Cancer, NSCLC Trial in Worldwide (NovoTTF-200T, Immune checkpoint inhibitors or docetaxel)
Active, not recruiting
- Nonsmall Cell Lung Cancer
- NSCLC
- NovoTTF-200T
- Immune checkpoint inhibitors or docetaxel
-
Birmingham, Alabama
- +123 more
Oct 13, 2022
Brain Metastases Trial in Changsha (ASCLU-300 TTF)
Recruiting
- Brain Metastases
- ASCLU-300 TTF
-
Changsha, Hunan, ChinaXiangya Hospital Central South University
Feb 27, 2022
Advanced Breast Carcinoma, Advanced Endometrial Carcinoma, Advanced Fallopian Tube Carcinoma Trial in Houston (biological, drug,
Recruiting
- Advanced Breast Carcinoma
- +73 more
- Atezolizumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
May 5, 2022
Pancreas Cancer, Locally Advanced, Locally Advanced Pancreatic Adenocarcinoma Trial in Miami (Stereotactic Ablative Body
Not yet recruiting
- Pancreas Cancer
- +2 more
- Stereotactic Ablative Body Radiation (SABR)
- Tumor Treating Fields (TTF)
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
Dec 27, 2022
Locally Advanced Pancreatic Cancer Trial in Shanghai (Tumor treating fields combined with Gemcitabine HCl and albumin binding
Not yet recruiting
- Locally Advanced Pancreatic Cancer
- Tumor treating fields combined with Gemcitabine hydrochloride and albumin binding paclitaxel
- Gemcitabine hydrochloride and albumin binding paclitaxel
-
Shanghai, Shanghai, ChinaHuashan Hospital Affiliated to Fudan University
Dec 8, 2022
Uveal Melanoma Trial in Scottsdale (Novocure Optune, Opdivo, Yervoy)
Recruiting
- Uveal Melanoma
- Novocure Optune
- +2 more
-
Scottsdale, ArizonaHonorHealth Research Institute
Mar 21, 2022